Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment

Sleep Medicine

Volumn 11, Issue 7, 2010, Pages 643-651

  Picchietti, Matthew A ^a   Picchietti, Daniel L ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Attention deficit hyperactivity disorder; Children; Ferritin; Genetics; Periodic limb movement disorder; Periodic limb movements in sleep; Restless legs syndrome; Treatment

Indexed keywords

AMFEBUTAMONE; CARBIDOPA PLUS LEVODOPA; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; FERRIC HYDROXIDE SUCROSE; FERRITIN; GABAPENTIN; GABAPENTIN ENACARBIL; IRON; IRON DEXTRAN; IRON POLYMALTOSE; PLACEBO; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE; TEMAZEPAM; ZOLPIDEM;

ANXIETY; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; CLINICAL TRIAL; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; EARLY DIAGNOSIS; EVENING DOSAGE; FAMILY RELATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTERVIEW; IRON DEFICIENCY; IRON THERAPY; MORNING DOSAGE; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; RISK FACTOR; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD; CHILD; COMORBIDITY; GENETIC PREDISPOSITION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRON; RESTLESS LEGS SYNDROME;

EID: 77954958574     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.11.014     Document Type: Review

References (160)

1. Walters A.S., Picchietti D.L., Ehrenberg B.L., Wagner M.L. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994, 11(3):241-245.
2. Picchietti M.A., Picchietti D.L. Restless legs syndrome and periodic limb movement disorder in children and adolescents. Semin Pediatr Neurol 2008, 15(2):91-99.
3. Simakajornboon N., Kheirandish-Gozal L., Gozal D. Diagnosis and management of restless legs syndrome in children. Sleep Med Rev 2009, 13(2):149-156.
4. Hornyak M., Feige B., Voderholzer U., Philipsen A., Riemann D. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep 2007, 30(7):861-865.
5. Hornyak M., Kopasz M., Berger M., Riemann D., Voderholzer U. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 2005, 66(9):1139-1145.
6. Walters A.S., Silvestri R., Zucconi M., Chandrashekariah R., Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med 2008, 4(6):591-600.
7. Abetz L., Allen R., Washburn T., Early C. The impact of restless legs syndrome (RLS) on sleep and cognitive function. Eur J Neurol 2004, 9(Suppl. 2):50.
8. Abetz L., Allen R., Follet A., Washburn T., Early C., Kirsch J., et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004, 26(6):925-935.
9. Allen R.P., Walters A.S., Montplaisir J., Hening W., Myers A., Bell T.J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165(11):1286-1292.
10. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health. Sleep Med 2003, 4(2):101-119.
11. Earley C.J. Clinical practice. Restless legs syndrome. N Engl J Med 2003, 348(21):2103-2109.
12. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997, 12(1):61-65.
13. Picchietti D., Allen R.P., Walters A.S., Davidson J.E., Myers A., Ferini-Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics 2007, 120(2):253-266.
14. Kinkelbur J., Hellwig J., Hellwig M. Frequency of RLS symptoms in childhood. Somnologie 2003, 7(Suppl. 1):34.
15. Kotagal S., Silber M.H. Childhood-onset restless legs syndrome. Ann Neurol 2004, 56(6):803-807.
16. Davis I.D., Baron J., O'Riordan M.A., Rosen C.L. Sleep disturbances in pediatric dialysis patients. Pediatr Nephrol 2005, 20(1):69-75.
17. Applebee G.A., Guillot A.P., Schuman C.C., Teddy S., Attarian H.P. Restless legs syndrome in pediatric patients with chronic kidney disease. Pediatr Nephrol 2009, 24(3):545-548.
18. Sinha R., Davis I.D., Matsuda-Abedini M. Sleep disturbances in children and adolescents with non-dialysis-dependent chronic kidney disease. Arch Pediatr Adolesc Med 2009, 163(9):850-855.
19. Winkelman J.W., Chertow G.M., Lazarus J.M. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996, 28(3):372-378.
20. Mucsi I., Molnar M.Z., Ambrus C., Szeifert L., Kovacs A.Z., Zoller R., et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 2005, 20(3):571-577.
21. Iber C., Ancoli-Israel S., Chesson A., Quan S.F. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, American Academy of Sleep Medicine, Westchester (IL). 1st ed.
22. Walters A.S., Lavigne G., Hening W., Picchietti D.L., Allen R.P., Chokroverty S., et al. The scoring of movements in sleep. J Clin Sleep Med 2007, 3(2):155-167.
23. Zucconi M., Ferri R., Allen R., Baier P.C., Bruni O., Chokroverty S., et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006, 7(2):175-183.
24. American academy of sleep medicine. International classification of sleep disorders, diagnostic and coding manual. 2nd ed. Westchester (IL): American Academy of Sleep Medicine; 2005.
25. Pennestri M.H., Montplaisir J., Colombo R., Lavigne G., Lanfranchi P.A. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007, 68(15):1213-1218.
26. Siddiqui F., Strus J., Ming X., Lee I.A., Chokroverty S., Walters A.S. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol 2007, 118(9):1923-1930.
27. Walters A.S., Rye D.B. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009, 32(5):589-597.
28. Walter L.M., Foster A.M., Patterson R.R., Anderson V., Davey M.J., Nixon G.M., et al. Cardiovascular variability during periodic leg movements in sleep in children. Sleep 2009, 32(8):1093-1099.
29. Picchietti D.L., England S.J., Walters A.S., Willis K., Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998, 13(12):588-594.
30. Picchietti D.L., Underwood D.J., Farris W.A., Walters A.S., Shah M.M., Dahl R.E., et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 1999, 14(6):1000-1007.
31. Crabtree V.M., Ivanenko A., O'Brien L.M., Gozal D. Periodic limb movement disorder of sleep in children. J Sleep Res 2003, 12(1):73-81.
32. Traeger N., Schultz B., Pollock A.N., Mason T., Marcus C.L., Arens R. Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 2005, 40(1):22-30.
33. Montgomery-Downs H.E., O'Brien L.M., Gulliver T.E., Gozal D. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006, 117(3):741-753.
34. Pennestri M.H., Whittom S., Adam B., Petit D., Carrier J., Montplaisir J. PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution. Sleep 2006, 29(9):1183-1187.
35. O'Brien L.M., Holbrook C.R., Faye Jones V., Gozal D. Ethnic difference in periodic limb movements in children. Sleep Med 2007, 8(3):240-246.
36. Gaultney J.F., Merchant K., Gingras J.L. Parents of children with periodic limb movement disorder versus sleep-disordered breathing report greater daytime mood and behavior difficulties in their child: the importance of using ICSD-2nd Edition criteria to define a PLMD study group. Behav Sleep Med 2009, 7(3):119-135.
37. Trotti L.M., Bliwise D.L., Greer S.A., Sigurdsson A.P., Gudmundsdottir G.B., Wessel T., et al. Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis. Sleep Med 2009, 10(6):668-671.
38. Muhle H., Neumann A., Lohmann-Hedrich K., Lohnau T., Lu Y., Winkler S., et al. Childhood-onset restless legs syndrome: clinical and genetic features of 22 families. Mov Disord 2008, 23(8):1113-1121.
39. Picchietti D.L., Rajendran R.R., Wilson M.P., Picchietti M.A. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs. Sleep Med 2009, 10:925-931.
40. Picchietti M.A., Picchietti D.L., England S.J., Walters A.S., Couvadelli B.V., Lewin D.S., et al. Children show individual night-to-night variability of periodic limb movements in sleep. Sleep 2009, 32(4):530-535.
41. Stefansson H., Rye D.B., Hicks A., Petursson H., Ingason A., Thorgeirsson T.E., et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357(7):639-647.
42. Bassetti C.L., Kretzschmar U., Werth E., Baumann C.R. Restless legs and restless legs-like syndrome. Sleep Med 2006, 7(6):534.
43. Winkelman J.W. Periodic limb movements in sleep-endophenotype for restless legs syndrome?. N Engl J Med 2007, 357(7):703-705.
44. Allen R.P. Improving RLS diagnosis and severity assessment: polysomnography, actigraphy and RLS-sleep log. Sleep Med 2007, 8(Suppl. 2):S13-S18.
45. Fulda S., Wetter T.C. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain 2008, 131(Pt 4):902-917.
46. Picchietti D., Stevens H.E. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008, 9:770-781.
47. Yang C., White D.P., Winkelman J.W. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005, 58:510-514.
48. Picchietti D. Periodic limb movements in sleep: irrelevant epiphenomenon, marker for a potential problem, or a disorder?. J Clin Sleep Med 2006, 2(4):446-447.
49. Arens R., Wright B., Elliott J., Zhao H., Wang P.P., Brown L.W., et al. Periodic limb movement in sleep in children with Williams syndrome. J Pediatr 1998, 133(5):670-674.
50. Miano S., Bruni O., Elia M., Musumeci S.A., Verrillo E., Ferri R. Sleep breathing and periodic leg movement pattern in Angelman syndrome: a polysomnographic study. Clin Neurophysiol 2005, 116(11):2685-2692.
51. Ferri R., Zucconi M., Manconi M., Bruni O., Ferini-Strambi L., Vandi S., et al. Different periodicity and time structure of leg movements during sleep in narcolepsy/cataplexy and restless legs syndrome. Sleep 2006, 29(12):1587-1594.
52. Ferri R., Franceschini C., Zucconi M., Drago V., Manconi M., Vandi S., et al. Sleep polygraphic study of children and adolescents with narcolepsy/cataplexy. Dev Neuropsychol 2009, 34(5):523-538.
53. Manconi M., Ferri R., Zucconi M., Fantini M.L., Plazzi G., Ferini-Strambi L. Time structure analysis of leg movements during sleep in REM sleep behavior disorder. Sleep 2007, 30(12):1779-1785.
54. Manconi M., Vitale G., Ferri R., Zucconi M., Ferini-Strambi L. Periodic leg movements in Cheyne-Stokes respiration. Eur Respir J 2008, 32(6):1656-1662.
55. Ferri R., Manconi M., Lanuzza B., Cosentino F.I., Bruni O., Ferini-Strambi L., et al. Age-related changes in periodic leg movements during sleep in patients with restless legs syndrome. Sleep Med 2008, 9(7):790-798.
56. Beard J.L., Connor J.R. Iron status and neural functioning. Annu Rev Nutr 2003, 23:41-58.
57. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004, 5(4):385-391.
58. Burhans M.S., Dailey C., Beard Z., Wiesinger J., Murray-Kolb L., Jones B.C., et al. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci 2005, 8(1):31-38.
59. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Ondo W.G., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61(3):304-309.
60. Earley C.J., Barker P.B., Horska A., Allen R.P. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 2006, 7(5):458-461.
61. Godau J., Klose U., Di Santo A., Schweitzer K., Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord 2008, 23(8):1184-1187.
62. Godau J., Wevers A.K., Gaenslen A., Di Santo A., Liepelt I., Gasser T., et al. Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med 2008, 9(7):782-789.
63. Earley C.J., Connor J.R., Beard J.L., Clardy S.L., Allen R.P. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep 2005, 28(9):1069-1075.
64. Earley C.J., Horska A., Mohamed M.A., Barker P.B., Beard J.L., Allen R.P. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10(2):206-211.
65. Grote L., Leissner L., Hedner J., Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24(10):1445-1452.
66. Allen R.P., Butcher A., Du W. Double-blind, placebo-controlled multicenter evaluation of restless legs syndrome treatment with 1000mg of IV iron (ferric carboxymaltose). Sleep 2009, 32:A294-A295.
67. Davis B.J., Rajput A., Rajput M.L., Aul E.A., Eichhorn G.R. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000, 43(2):70-75.
68. Wang J., O'Reilly B., Venkataraman R., Mysliwiec V., Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009, 10(9):973-975.
69. O'Keeffe S.T., Gavin K., Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 1994, 23(3):200-203.
70. Sun E.R., Chen C.A., Ho G., Earley C.J., Allen R.P. Iron and the restless legs syndrome. Sleep 1998, 21(4):371-377.
71. Frauscher B., Gschliesser V., Brandauer E., El-Demerdash E., Kaneider M., Rucker L., et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009, 10(6):611-615.
72. Trenkwalder C., Hogl B., Benes H., Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008, 9(5):572-574.
73. Banno K., Koike S., Yamamoto K. Restless legs syndrome in a 5-year-old boy with low body stores of iron. Sleep Biol Rhythms 2009, 7(1):52-54.
74. Mohri I., Kato-Nishimura K., Tachibana N., Ozono K., Taniike M. Restless legs syndrome (RLS): an unrecognized cause for bedtime problems and insomnia in children. Sleep Med 2008, 9(6):701-702.
75. Starn A.L., Udall J.N. Iron deficiency anemia, pica, and restless legs syndrome in a teenage girl. Clin Pediatr (Phila) 2008, 47(1):83-85.
76. Kryger M.H., Otake K., Foerster J. Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med 2002, 3(2):127-132.
77. Simakajornboon N., Gozal D., Vlasic V., Mack C., Sharon D., McGinley B.M. Periodic limb movements in sleep and iron status in children. Sleep 2003, 26(6):735-738.
78. Simakajornboon N., Kheirandish-Gozal L., Gozal D., Sharon D., Murry L., Abraham M. A long-term follow-up study of periodic limb movement disorders in children after iron therapy (abstract). Sleep 2006, 29:A76-A77.
79. Centers for disease control and prevention. National report on biochemical indicators of diet and nutrition in the US. Population 1999-2002, iron-status indicators. Available from: <>; 2008 [accessed 10.04.09]. http://www.cdc.gov/nutritionreport/part_3.html.
80. Picchietti D. Is iron deficiency an underlying cause of pediatric restless legs syndrome and of attention-deficit/hyperactivity disorder?. Sleep Med 2007, 8:693-694.
81. Cortese S., Lecendreux M., Bernardina B.D., Mouren M.C., Sbarbati A., Konofal E. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis. Med Hypotheses 2008, 70(6):1128-1132.
82. Cortese S., Konofal E., Bernardina B.D., Mouren M.C., Lecendreux M. Sleep disturbances and serum ferritin levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2009, 18(7):393-399.
83. Konofal E., Lecendreux M., Arnulf I., Mouren M.C. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004, 158(12):1113-1115.
84. Millichap J.G., Yee M.M., Davidson S.I. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2006, 34(3):200-203.
85. Konofal E., Cortese S., Marchand M., Mouren M.C., Arnulf I., Lecendreux M. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 2007, 8(7-8):711-715.
86. Oner P., Oner O. Relationship of ferritin to symptom ratings children with attention deficit hyperactivity disorder: effect of comorbidity. Child Psychiatry Hum Dev 2008, 39(3):323-330.
87. Oner O., Alkar O.Y., Oner P. Relation of ferritin levels with symptom ratings and cognitive performance in children with attention deficit-hyperactivity disorder. Pediatr Int 2008, 50(1):40-44.
88. Sever Y., Ashkenazi A., Tyano S., Weizman A. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology 1997, 35(4):178-180.
89. Konofal E., Cortese S., Lecendreux M., Arnulf I., Mouren M.C. Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder. Pediatrics 2005, 116(5):e732-e734.
90. Konofal E., Lecendreux M., Deron J., Marchand M., Cortese S., Zaim M., et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008, 38(1):20-26.
91. Oner P., Dirik E.B., Taner Y., Caykoylu A., Anlar O. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med 2007, 213(3):269-276.
92. Silvestri R., Gagliano A., Arico I., Calarese T., Cedro C., Bruni O., et al. Sleep disorders in children with attention-deficit/hyperactivity disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med 2009, 10(10):1132-1138.
93. Wagner M.L., Walters A.S., Fisher B.C. Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome. Sleep 2004, 27(8):1499-1504.
94. Wiggs L., Montgomery P., Stores G. Actigraphic and parent reports of sleep patterns and sleep disorders in children with subtypes of attention-deficit hyperactivity disorder. Sleep 2005, 28(11):1437-1445.
95. Sevim S., Dogu O., Kaleagasi H., Aral M., Metin O., Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004, 75(2):226-230.
96. Picchietti D., Winkelman J.W. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005, 28(7):891-898.
97. Winkelmann J., Prager M., Lieb R., Pfister H., Spiegel B., Wittchen H.U., et al. " Anxietas Tibiarum" depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005, 252(1):67-71.
98. Lee H.B., Hening W.A., Allen R.P., Kalaydjian A.E., Earley C.J., Eaton W.W., et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008, 20(1):101-105.
99. Cortese S., Konofal E., Lecendreux M., Arnulf I., Mouren M.C., Darra F., et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 2005, 28(8):1007-1013.
100. Hanson M., Honour M., Singleton A., Crawley A., Hardy J., Gwinn-Hardy K. Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features. J Neurol 2004, 251(11):1398-1401.
101. Whittom S., Dauvilliers Y., Pennestri M.H., Vercauteren F., Molinari N., Petit D., et al. Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 2007, 9:54-59.
102. Lavigne G.J., Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994, 17(8):739-743.
103. Ondo W., Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996, 47(6):1435-1441.
104. Walters A.S., Hickey K., Maltzman J., Verrico T., Joseph D., Hening W., et al. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology 1996, 46(1):92-95.
105. Allen R.P., Earley C.J. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000, 1(1):11-19.
106. Winkelmann J., Wetter T.C., Collado-Seidel V., Gasser T., Dichgans M., Yassouridis A., et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000, 23(5):597-602.
107. Bassetti C.L., Mauerhofer D., Gugger M., Mathis J., Hess C.W. Restless legs syndrome: a clinical study of 55 patients. Eur Neurol 2001, 45(2):67-74.
108. Winkelmann J., Polo O., Provini F., Nevsimalova S., Kemlink D., Sonka K., et al. Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord 2007, 22:S449-S458.
109. Rutter M., Moffitt T.E., Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006, 47(3-4):226-261.
110. Winkelmann J., Schormair B., Lichtner P., Ripke S., Xiong L., Jalilzadeh S., et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39(8):1000-1006.
111. Schormair B., Kemlink D., Roeske D., Eckstein G., Xiong L., Lichtner P., et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008, 40(8):946-948.
112. Vilarino-Guell C., Farrer M.J., Lin S.C. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2008, 358(4):425-427.
113. Kemlink D., Polo O., Frauscher B., Gschlieser V., Hogl B., Poewe W., et al. Replication of restless legs syndrome loci in three european populations. J Med Genet 2009, 46(5):315-318.
114. Schimmelmann B.G., Friedel S., Nguyen T.T., Sauer S., Ganz Vogel C.I., Konrad K., et al. Exploring the genetic link between RLS and ADHD. J Psychiatr Res 2009, 43(10):941-945.
115. Stafstrom C.E. Using artwork to better understand patients with neurologic disorders. Epilepsy Behav 2005, 6(2):113-114.
116. Stafstrom C.E., Goldenholz S.R., Dulli D.A. Serial headache drawings by children with migraine: correlation with clinical headache status. J Child Neurol 2005, 20(10):809-813.
117. Anschel D.J., Dolce S., Schwartzman A., Fisher R.S. A blinded pilot study of artwork in a comprehensive epilepsy center population. Epilepsy Behav 2005, 6(2):196-202.
118. Stefanatou A., Bowler D. Depiction of pain in the self-drawings of children with sickle cell disease. Child Care Health Dev 1997, 23(2):135-155.
119. Tuisku K., Holi M.M., Wahlbeck K., Ahlgren A.J., Lauerma H. Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: a controlled study. Mov Disord 2003, 18(4):442-448.
120. Sforza E., Johannes M., Claudio B. The PAM-RL ambulatory device for detection of periodic leg movements: a validation study. Sleep Med 2005, 6(5):407-413.
121. Aukerman M.M., Aukerman D., Bayard M., Tudiver F., Thorp L., Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2006, 19(5):487-493.
122. Deslandes A., Moraes H., Ferreira C., Veiga H., Silveira H., Mouta R., et al. Exercise and mental health: many reasons to move. Neuropsychobiology 2009, 59(4):191-198.
123. Dworak M., Wiater A., Alfer D., Stephan E., Hollmann W., Struder H.K. Increased slow wave sleep and reduced stage 2 sleep in children depending on exercise intensity. Sleep Med 2008, 9(3):266-272.
124. Gamaldo C.E., Earley C.J. Restless legs syndrome: a clinical update. Chest 2006, 130(5):1596-1604.
125. Cohrs S. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 2008, 22(11):939-962.
126. Silber M.H., Ehrenberg B.L., Allen R.P., Buchfuhrer M.J., Earley C.J., Hening W.A., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004, 79(7):916-922.
127. Barton J.C., Wooten V.D., Acton R.T. Hemochromatosis and iron therapy of restless legs syndrome. Sleep Med 2001, 2(3):249-251.
128. Eskeland B., Baerheim A., Ulvik R., Hunskaar S. Influence of mild infections on iron status parameters in women of reproductive age. Scand J Prim Health Care 2002, 20(1):50-56.
129. Mindell J.A., Emslie G., Blumer J., Genel M., Glaze D., Ivanenko A., et al. Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics 2006, 117(6):e1223-e1232.
130. Newcorn J.H., Schulz K., Harrison M., DeBellis M.D., Udarbe J.K., Halperin J.M. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am 1998, 45(5):1022-1099. [viii].
131. Owens J.A., Rosen C.L., Mindell J.A. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics 2003, 111(5 Pt 1):e628-e635.
132. Prince J.B., Wilens T.E., Biederman J., Spencer T.J., Wozniak J.R. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 1996, 35(5):599-605.
133. Garcia-Borreguero D., Larrosa O., de la Llave Y., Verger K., Masramon X., Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002, 59(10):1573-1579.
134. Happe S., Sauter C., Klosch G., Saletu B., Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003, 48(2):82-86.
135. Hening W., Allen R., Earley C., Kushida C., Picchietti D., Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An american academy of sleep medicine review. Sleep 1999, 22(7):970-999.
136. Trenkwalder C., Hogl B., Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009, 256(4):539-553.
137. Hening W.A., Allen R.P., Earley C.J., Picchietti D.L., Silber M.H. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004, 27(3):560-583.
138. Cortese S., Konofal E., Lecendreux M. Effectiveness of ropinirole for RLS and depressive symptoms in an 11-year-old girl. Sleep Med 2009, 10(2):259-261.
139. Picchietti D.L., Walters A.S. Moderate to severe periodic limb movement disorder in childhood and adolescence. Sleep 1999, 22(3):297-300.
140. Guilleminault C., Palombini L., Pelayo R., Chervin R.D. Sleepwalking and sleep terrors in prepubertal children: what triggers them?. Pediatrics 2003, 111(1):e17-25.
141. Konofal E., Arnulf I., Lecendreux M., Mouren M.C. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol 2005, 32:350-351.
142. Martinez S., Guilleminault C. Periodic leg movements in prepubertal children with sleep disturbance. Dev Med Child Neurol 2004, 46(11):765-770.
143. Walters A.S., Mandelbaum D.E., Lewin D.S., Kugler S., England S.J., Miller M. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic therapy study group. Pediatr Neurol 2000, 22(3):182-186.
144. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19(3):205-213.
145. Garcia-Borreguero D., Allen R.P., Kohnen R., Hogl B., Trenkwalder C., Oertel W., et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a world association of sleep medicine-international restless legs syndrome study group consensus conference at the Max Planck institute. Sleep Med 2007, 8(5):520-530.
146. Tippmann-Peikert M., Park J.G., Boeve B.F., Shepard J.W., Silber M.H. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007, 68(4):301-303.
147. Gordon N. Segawa's disease: dopa-responsive dystonia. Int J Clin Pract 2008, 62(6):943-946.
148. Trenkwalder C., Benes H., Poewe W., Oertel W.H., Garcia-Borreguero D., de Weerd A.W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7(7):595-604.
149. Kushida C.A., Walters A.S., Becker P., Thein S.G., Perkins A.T., Roth T., et al. A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Sleep 2009, 32(2):159-168.
150. Sommer M., Bachmann C.G., Liebetanz K.M., Schindehutte J., Tings T., Paulus W. Pregabalin in restless legs syndrome with and without neuropathic pain. Acta Neurol Scand 2007, 115(5):347-350.
151. Lettieri C.J., Eliasson A.H. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest 2009, 135(1):74-80.
152. O'Brien L.M., Ivanenko A., Crabtree V.M., Holbrook C.R., Bruner J.L., Klaus C.J., et al. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. Sleep Med 2003, 4(4):309-316.
153. Sobanski E., Schredl M., Kettler N., Alm B. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 2008, 31(3):375-381.
154. Kim S.W., Shin I.S., Kim J.M., Yang S.J., Shin H.Y., Yoon J.S. Bupropion may improve restless legs syndrome: a report of three cases. Clin Neuropharmacol 2005, 28(6):298-301.
155. Malek-Ahmadi P. Bupropion, periodic limb movement disorder, and ADHD (letter). J Am Acad Child Adolesc Psychiatry 1999, 38(6):637-638.
156. Nofzinger E.A., Fasiczka A., Berman S., Thase M.E. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000, 61(11):858-862.
157. Trivedi M.H., Rush A.J., Carmody T.J., Donahue R.M., Bolden-Watson C., Houser T.L., et al. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?. J Clin Psychiatry 2001, 62(10):776-781.
158. Corrigan M.H., Denahan A.Q., Wright C.E., Ragual R.J., Evans D.L. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 2000, 11(2):58-65.
159. Rektorova I., Rektor I., Bares M., Dostal V., Ehler E., Fanfrdlova Z., et al. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol 2003, 10(4):399-406.
160. Sporn J., Ghaemi S.N., Sambur M.R., Rankin M.A., Recht J., Sachs G.S., et al. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry 2000, 12(3):137-140.